vs
Side-by-side financial comparison of Clarus Corp (CLAR) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Clarus Corp is the larger business by last-quarter revenue ($65.4M vs $57.3M, roughly 1.1× RHYTHM PHARMACEUTICALS, INC.). Clarus Corp runs the higher net margin — -47.8% vs -83.0%, a 35.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -8.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -2.9%).
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CLAR vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.4M | $57.3M |
| Net Profit | $-31.3M | $-47.5M |
| Gross Margin | 27.7% | 91.6% |
| Operating Margin | -59.6% | -82.2% |
| Net Margin | -47.8% | -83.0% |
| Revenue YoY | -8.4% | 36.9% |
| Net Profit YoY | 52.3% | -9.6% |
| EPS (diluted) | $-0.81 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $65.4M | $57.3M | ||
| Q3 25 | $69.3M | $51.3M | ||
| Q2 25 | $55.2M | $48.5M | ||
| Q1 25 | $60.4M | $32.7M | ||
| Q4 24 | $71.4M | $41.8M | ||
| Q3 24 | $67.1M | $33.3M | ||
| Q2 24 | $56.5M | $29.1M | ||
| Q1 24 | $69.3M | $26.0M |
| Q4 25 | $-31.3M | $-47.5M | ||
| Q3 25 | $-1.6M | $-52.9M | ||
| Q2 25 | $-8.4M | $-46.6M | ||
| Q1 25 | $-5.2M | $-49.5M | ||
| Q4 24 | $-65.5M | $-43.3M | ||
| Q3 24 | $-3.2M | $-43.6M | ||
| Q2 24 | $-5.5M | $-32.3M | ||
| Q1 24 | $21.9M | $-141.4M |
| Q4 25 | 27.7% | 91.6% | ||
| Q3 25 | 35.1% | 89.3% | ||
| Q2 25 | 35.6% | 88.6% | ||
| Q1 25 | 34.4% | 88.8% | ||
| Q4 24 | 33.4% | 90.9% | ||
| Q3 24 | 35.0% | 88.5% | ||
| Q2 24 | 36.1% | 89.9% | ||
| Q1 24 | 35.9% | 89.2% |
| Q4 25 | -59.6% | -82.2% | ||
| Q3 25 | -4.4% | -102.6% | ||
| Q2 25 | -19.7% | -93.4% | ||
| Q1 25 | -11.2% | -143.7% | ||
| Q4 24 | -70.2% | -98.6% | ||
| Q3 24 | -8.0% | -132.0% | ||
| Q2 24 | -14.4% | -139.2% | ||
| Q1 24 | -9.8% | -538.7% |
| Q4 25 | -47.8% | -83.0% | ||
| Q3 25 | -2.3% | -103.1% | ||
| Q2 25 | -15.3% | -96.1% | ||
| Q1 25 | -8.7% | -151.4% | ||
| Q4 24 | -91.8% | -103.6% | ||
| Q3 24 | -4.7% | -131.2% | ||
| Q2 24 | -9.7% | -110.9% | ||
| Q1 24 | 31.6% | -544.4% |
| Q4 25 | $-0.81 | $-0.73 | ||
| Q3 25 | $-0.04 | $-0.82 | ||
| Q2 25 | $-0.22 | $-0.75 | ||
| Q1 25 | $-0.14 | $-0.81 | ||
| Q4 24 | $-1.72 | $-0.71 | ||
| Q3 24 | $-0.08 | $-0.73 | ||
| Q2 24 | $-0.14 | $-0.55 | ||
| Q1 24 | $0.57 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.7M | $388.9M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $196.4M | $139.1M |
| Total Assets | $249.0M | $480.2M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.7M | $388.9M | ||
| Q3 25 | $29.5M | $416.1M | ||
| Q2 25 | $28.5M | $291.0M | ||
| Q1 25 | $41.3M | $314.5M | ||
| Q4 24 | $45.4M | $320.6M | ||
| Q3 24 | $36.4M | $298.4M | ||
| Q2 24 | $46.2M | $319.1M | ||
| Q1 24 | $47.5M | $201.2M |
| Q4 25 | $0 | — | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $1.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $37.0K | — |
| Q4 25 | $196.4M | $139.1M | ||
| Q3 25 | $225.8M | $148.8M | ||
| Q2 25 | $225.1M | $-11.9M | ||
| Q1 25 | $229.3M | $18.9M | ||
| Q4 24 | $233.1M | $21.7M | ||
| Q3 24 | $308.5M | $11.2M | ||
| Q2 24 | $307.3M | $39.3M | ||
| Q1 24 | $310.4M | $61.6M |
| Q4 25 | $249.0M | $480.2M | ||
| Q3 25 | $283.1M | $506.9M | ||
| Q2 25 | $286.5M | $372.7M | ||
| Q1 25 | $292.8M | $386.7M | ||
| Q4 24 | $294.1M | $392.3M | ||
| Q3 24 | $375.3M | $363.6M | ||
| Q2 24 | $369.4M | $381.8M | ||
| Q1 24 | $377.0M | $258.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.5M | $-25.4M |
| Free Cash FlowOCF − Capex | $11.6M | — |
| FCF MarginFCF / Revenue | 17.7% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.5M | $-25.4M | ||
| Q3 25 | $-5.7M | $-26.6M | ||
| Q2 25 | $-9.4M | $-23.3M | ||
| Q1 25 | $-2.1M | $-40.4M | ||
| Q4 24 | $16.6M | $-18.8M | ||
| Q3 24 | $-8.3M | $-25.2M | ||
| Q2 24 | $834.0K | $-29.1M | ||
| Q1 24 | $-16.4M | $-40.7M |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $-7.0M | — | ||
| Q2 25 | $-11.3M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $-9.4M | — | ||
| Q2 24 | $-744.0K | — | ||
| Q1 24 | $-18.3M | — |
| Q4 25 | 17.7% | — | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | -20.4% | — | ||
| Q1 25 | -5.4% | — | ||
| Q4 24 | 20.1% | — | ||
| Q3 24 | -14.0% | — | ||
| Q2 24 | -1.3% | — | ||
| Q1 24 | -26.3% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
RYTM
Segment breakdown not available.
